Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angular Ventures is an active early-stage venture capital firm focused on backing technical founders, primarily in enterprise software, deep technology, and related hard-tech markets in Europe and Israel. The firm describes itself as an inception-stage investor and typically participates in first institutional rounds, often investing before product or revenue. Angular Ventures is not a biotech, pharma, life science, or healthcare operating company and does not appear to develop therapeutic products of its own. Instead, it provides venture financing, network access, and company-building support to portfolio companies across technology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angular Ventures.